Patents by Inventor Chris Przybyszewski

Chris Przybyszewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11576868
    Abstract: The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioactive agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: February 14, 2023
    Assignee: US Biologic, Inc.
    Inventors: Douglas Steven Zatechka, Mason Kauffman, Chris Przybyszewski
  • Publication number: 20210069116
    Abstract: The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioactive agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.
    Type: Application
    Filed: April 15, 2020
    Publication date: March 11, 2021
    Inventors: Douglas Steven Zatechka, Mason Kauffman, Chris Przybyszewski
  • Patent number: 10653630
    Abstract: The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioacitve agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: May 19, 2020
    Assignee: US Biologic, Inc.
    Inventors: Douglas Steven Zatechka, Mason Kauffman, Chris Przybyszewski
  • Publication number: 20180153945
    Abstract: The invention relates to recombinant vaccines capable of presenting all, or antigenic portions of, the Eimeria tenella 3-1e, or profilin. Also provided are methodologies of using the vaccines for oral administration to poultry and other targets in the control of coccidiosis. In particular embodiments, recombinant host cells, such as E. coli, expressing all or part of the 3-1e antigen, are provided that can be used as whole-cell vaccines. In some instances, the native 3-1e protein utilized in the vaccines presented herein is molecularly manipulated.
    Type: Application
    Filed: December 1, 2017
    Publication date: June 7, 2018
    Inventors: HYUN S. LILLEHOJ, WOOHYUN KIM, CHRIS PRZYBYSZEWSKI, D.STEVEN ZATECHKA, JR.
  • Publication number: 20170181975
    Abstract: The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioacitve agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.
    Type: Application
    Filed: December 21, 2016
    Publication date: June 29, 2017
    Inventors: Douglas Steven Zatechka, Mason Kauffman, Chris Przybyszewski